Share This Article:

Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine

Full-Text HTML Download Download as PDF (Size:171KB) PP. 1198-1202
DOI: 10.4236/jct.2013.47139    3,070 Downloads   4,302 Views Citations

ABSTRACT

Background: The employment status of workers with cancer has important implications for impairment of intimate and family relationships and for economic, social and psychological health. The aim of the present study was to evaluate the effect of chemotherapy with capecitabine in patients with colorectal cancer on work productivity and daily activity. Methods: 30 patients with primary diagnosis of stage III colorectal cancer were enrolled for our study. All patients received capecitabine twice daily at a cumulative dose of 2500 mg/m2 on days 1 -14 and repeated on day 22. Work productivity was determined using the WPAI questionnaire. Results: We observed a significant increase in absenteeism after 1 cycle, after 6 cycles of therapy and at follow-up (p < 0.001). On the other hand, presenteeism, work productivity loss and daily activity impairment, increased after 1 cycle and 6 cycles of therapy, but we could not find statistically different significances. Conclusions: Colorectal cancer diagnosis and treatment are associated with frailty and vulnerability. Chemotherapy with capecitabine may result in negative consequences for job performance.

Cite this paper

G. Malaguarnera, M. Pennisi, G. Grosso, M. Vacante, S. Salomone, F. Drago, M. Malaguarnera, E. Ozyalcin, M. Motta, V. Raciti and M. Malaguarnera, "Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine," Journal of Cancer Therapy, Vol. 4 No. 7, 2013, pp. 1198-1202. doi: 10.4236/jct.2013.47139.

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.